ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?
about
The Role of Oxidative Stress in Myocardial Ischemia and Reperfusion Injury and Remodeling: RevisitedReviews on Mechanisms of In Vitro Antioxidant Activity of PolysaccharidesMechanisms of superoxide signaling in epigenetic processes: relation to aging and cancerDifferential Role of Leptin and Adiponectin in Cardiovascular SystemBang-bang model for regulation of local blood flowOxidative stress and antioxidant activity in hypothermia and rewarming: can RONS modulate the beneficial effects of therapeutic hypothermia?MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H₂O₂)-induced apoptosis through targeting the mitochondria apoptotic pathwayAngiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathwaySodium channels as gateable non-photonic sensors for membrane-delimited reactive speciesThe role of Nrf2-mediated pathway in cardiac remodeling and heart failure.Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes.Reactive Secondary Sequence Oxidative Pathology Polymer Model and Antioxidant Tests.Serendipitous discovery of a novel protein signaling mechanism in heart failure.Reactive oxygen species scavenger N-acetyl cysteine reduces methamphetamine-induced hyperthermia without affecting motor activity in mice.Atrial remodelling in atrial fibrillation: CaMKII as a nodal proarrhythmic signalOxidative stress in cardiovascular diseases and obesity: role of p66Shc and protein kinase C.Protection of oral hydrogen water as an antioxidant on pulmonary hypertensionOxidative stress and autophagy in cardiovascular homeostasis.Flavonoids inhibit the respiratory burst of neutrophils in mammals.Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation.Nrf2 and cardiovascular defense.5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway.Oxidative Stress and Cardiovascular Aging: Interaction Between NRF-2 and ADMA.NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress.Thymosin beta 4 protects cardiomyocytes from oxidative stress by targeting anti-oxidative enzymes and anti-apoptotic genes.Sepsis-Induced Cardiomyopathy: Oxidative Implications in the Initiation and Resolution of the Damage.KMUP-1 Attenuates Endothelin-1-Induced Cardiomyocyte Hypertrophy through Activation of Heme Oxygenase-1 and Suppression of the Akt/GSK-3β, Calcineurin/NFATc4 and RhoA/ROCK Pathways.Peptides accompanying chicken egg yolk IgY--alternative methods of isolation and immunoregulatory activity.Propofol improves recovery of the isolated working hypertrophic heart from ischaemia-reperfusion.Low-Dose Endotoxin Induces Late Preconditioning, Increases Peroxynitrite Formation, and Activates STAT3 in the Rat Heart.PEDF improves cardiac function in rats subjected to myocardial ischemia/reperfusion injury by inhibiting ROS generation via PEDF‑R.Evidence for a hyper-reductive redox in a sub-set of heart failure patients.
P2860
Q26744642-E38F29A5-B512-4E76-AA29-9B97471F9855Q26774906-89B624C2-DD84-4562-8AED-3F4230797EBFQ26827947-3FEFAF8A-35C0-4C1A-9D1B-5A0C7A9DC0B1Q26864590-2242FB16-E6B9-4668-9DB0-CCDD817B57D7Q26998655-5D5E1D2A-2D68-4240-8E88-BFD8A398E147Q27011273-60455E04-530C-413B-9B84-C42C0BF3D61EQ28570497-8FF92B5C-CB7E-4B63-9822-EFA9DBF4898FQ28574928-030F0B50-9445-4A33-AD4F-6E82AE24D5BFQ33851056-5051BB7A-801B-417B-8934-492D5B549369Q33914944-0FECB9A2-9162-4B6C-8118-21CE06B2C3B4Q35128221-4AAA6764-DE0E-4CCF-A264-083F15A598EDQ35504522-98E6DE84-309C-48D8-8F5C-610ED59FE7B4Q35957438-D10489A9-F663-4D6F-91CA-46CDA6B4C7E6Q36020105-3936B80D-714E-44F6-9C31-E9CCC9F26ED8Q36650585-6CB3E948-5CDF-45A5-8A68-00D95384C71EQ36763396-49DF9CF7-0D4E-43CD-93A5-121160140570Q37115093-BDE7FAF5-6FB4-4B71-A04D-F0641CFDB68FQ37489807-07D98A56-C1B6-4E62-803B-69B7E48C9BAEQ38009317-CC38CDAC-4D09-41D5-BD51-DF8D17F44276Q38025390-5E4179DE-9AFA-49EA-95C3-616FD97C5A5CQ38108306-6B5F209A-58C7-4FE6-9FB9-B3EC03D9A1A9Q38912901-84FC6EF9-9C63-4A3B-9705-689AF2A118EEQ39142536-C5EE97C0-7190-452D-AB28-98C6352CBBBCQ41166567-9A6ADECA-AF71-4500-80B8-361BE026F7D8Q42261788-D7E7D223-AD8F-49CE-B7E2-CB728FA5B640Q46023760-DFF6E4EB-146B-46FC-ADD7-13A83E6B20A0Q46717606-0475454F-8C1B-4839-9C24-599832F3D155Q46930813-FB8F7970-15E6-4F7F-A6CC-E56D6B90297FQ48129009-3A184368-229C-45C9-A12B-2927882D5B38Q51102345-B106E89A-CFE4-4C28-B41C-1613BEC9FDA5Q51734412-8A30A1A3-7C01-43E3-B278-BEAE3EEF7498Q55401731-C6B93B6D-2DDB-4414-8A0C-718842241FE4
P2860
ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?
@en
ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?
@nl
type
label
ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?
@en
ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?
@nl
prefLabel
ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?
@en
ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?
@nl
P2860
P921
P356
P1476
ROS and RNS signaling in heart disorders: could antioxidant treatment be successful?
@en
P2093
Igor Afanas'ev
P2860
P304
P356
10.1155/2011/293769
P577
2011-09-08T00:00:00Z